Identification of a putative amyloid A4‐generating enzyme as a prolyl endopeptidase
Authors:
- Shoichi IshiuraSIShoichi Ishiura
- 15 January 1990
- journal article
- Published by Wiley in FEBS Letters
- Vol. 260 (1) , 131-134
Abstract
The A4 amyloid peptide is deposited in Alzheimer's disease inside neurons as neurofibrillary tangles or extracellularly as vascular amyloid. The A4 peptide is cleaved off by an unidentified proteinase from a larger precursor protein (APP), which resembles a cell surface receptor. The proteinase, which cleaves off the membrane‐spanning domain of APP, may be important in amyloid formation. To evaluate this, a model peptide substrate, succinyl‐ isoleucyl‐alanine‐methylcoumarinamide, which is homologous to the C‐terminal portion of A4 peptide, was synthesized to screen the putative A4‐generating proteinase. On chromatographie purification, it was found that two proteinases are involved in the hydrolysis of the peptide, the major one being identified as a prolyl endopeptidase. This evidence may facilitate elucidation of the mechanism of amyloid deposition in Alzheimer's disease.Keywords
This publication has 20 references indexed in Scilit:
- Addition of ATP increases the apparent molecular mass of the multicatalytic proteinase, ingensinFEBS Letters, 1989
- Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's DiseaseNew England Journal of Medicine, 1989
- Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid proteinCell, 1989
- Alterations in the extracellular domain of M13 procoat protein make its membrane insertion dependent on secA and secYEuropean Journal of Biochemistry, 1988
- An ATP‐dependent protease and ingensin, the multicatalytic proteinase, in K562 cellsEuropean Journal of Biochemistry, 1988
- Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activityNature, 1988
- Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's diseaseNature, 1988
- A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitorsNature, 1988
- Alzheimer's disease: Its proteins and genesCell, 1988
- Effect of Ca2+ on the inhibition of calcium‐activated neutral protease by leupeptin, antipain and epoxysuccinate derivativesFEBS Letters, 1981